The Swedish Cancer Institute integrates physician-led research with advanced technologies. The institute ensures comprehensive care from diagnosis to recovery, upholding a legacy of over 90 years in pioneering cancer research, clinical trials, evidence-based medicine and treatment in the western U.S. One recent advancement is spatial multiplex immunohistochemistry, which helps visualize and identify different types of immune cells in tumor tissues while retaining spatial information. These initiatives enhance personalized immunotherapies and have been instrumental in earning the designation of Clinical Radiopharmaceutical Therapy Center of Excellence from the Society of Nuclear Medicine & Molecular Imaging. Additionally, the institute is pioneering innovations in prostate cancer care, implementing over 3,000 minimally invasive robotic surgeries and targeted radiation therapies like stereotactic radiosurgery and brachytherapy. It also advocates for early detection through regular screenings. The institute is actively involved in hundreds of ongoing clinical trials and is often the only site in the Pacific Northwest, and sometimes globally, to participate in certain clinical trials.
